NCT01787747

Pharmacokinetics (PK) and Tolerability of AVP-786 in Healthy Volunteers

A Phase 1, Single-center, Randomized, Double-blind, Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Doses of AVP-786 (Deuterated Dextromethorphan) in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 48 (actual)
• Sponsor: Avanir Pharmaceuticals · Industry
• Sex: Male
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

To assess the single- and multiple-dose pharmacokinetic (PK), safety and tolerability of AVP-786 in healthy volunteers.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	AVP-786 Dose 1
DRUG	AVP-786 Dose 2
DRUG	AVP-786 Dose 1/Q Dose 1
DRUG	AVP-786 Dose 1/Q Dose 2
DRUG	AVP-786 Dose 2/Q Dose 2
DRUG	AVP-923

Timeline

• Start date: 2012-10-01
• Primary completion: 2013-02-01
• Completion: 2013-02-01
• First posted: 2013-02-11
• Last updated: 2014-06-26

Locations

1 site across 1 country: Australia